Premium
Bone marrow biopsy in low‐risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk group
Author(s) -
Bustoros Mark,
Kastritis Efstathios,
SklavenitisPistofidis Romanos,
Liu ChiaJen,
Hornburg Kalvis,
Kanellias Nikolaos,
Kim Geon,
Liu David,
Gavriatopoulou Maria,
Marinac Catherine R.,
Roussou Maria,
Migkou Magdalini,
Noonan Kimberly,
Reyes Kaitlen,
Rivotto Bradley,
Neuse Carl Jannes,
Ziogas Dimitrios C.,
Laubach Jacob,
Terpos Evangelos,
Anderson Kenneth C.,
Richardson Paul G.,
Ghobrial Irene M.,
Dimopoulos Meletios A.
Publication year - 2019
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25441
Subject(s) - monoclonal gammopathy of undetermined significance , multiple myeloma , medicine , bone marrow , biopsy , pathology , monoclonal , monoclonal antibody , immunology , antibody